These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 2543793)

  • 21. Differentiation of strains of yellow fever virus in gamma-irradiated mice.
    Fitzgeorge R; Bradish CJ
    J Gen Virol; 1980 Oct; 50(2):345-56. PubMed ID: 7463003
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Survival of mice immunized with monoclonal antibodies against glycoprotein E of Japanese encephalitis virus before or after infection with Japanese encephalitis, West Nile, and Dengue viruses.
    Gupta AK; Lad VJ; Koshy AA
    Acta Virol; 2008; 52(4):219-24. PubMed ID: 19143477
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reduction of yellow fever virus mouse neurovirulence by immunization with a bacterially synthesized non-structural protein (NS1) fragment.
    Cane PA; Gould EA
    J Gen Virol; 1988 Jun; 69 ( Pt 6)():1241-6. PubMed ID: 3133449
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of a yellow fever virus isolated from a fatal case of vaccine-associated human encephalitis.
    Jennings AD; Gibson CA; Miller BR; Mathews JH; Mitchell CJ; Roehrig JT; Wood DJ; Taffs F; Sil BK; Whitby SN
    J Infect Dis; 1994 Mar; 169(3):512-8. PubMed ID: 7908925
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of monoclonal antibodies that distinguish between 17D-204 and other strains of yellow fever virus.
    Barrett AD; Mathews JH; Miller BR; Medlen AR; Ledger TN; Roehrig JT
    J Gen Virol; 1990 Jan; 71 ( Pt 1)():13-8. PubMed ID: 1689367
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunological studies with group B arthropod-borne viruses. V. Evaluation of cross-immunity against type 1 dengue fever in human subjects convalescent from subclinical natural Japanese encephalitis virus infection and vaccinated with 17D strain yellow fever vaccine.
    Wisseman CL; Kitaoka M; Tamiya T
    Am J Trop Med Hyg; 1966 Jul; 15(4):588-600. PubMed ID: 4287392
    [No Abstract]   [Full Text] [Related]  

  • 27. Immunogenicity, genetic stability, and protective efficacy of a recombinant, chimeric yellow fever-Japanese encephalitis virus (ChimeriVax-JE) as a live, attenuated vaccine candidate against Japanese encephalitis.
    Guirakhoo F; Zhang ZX; Chambers TJ; Delagrave S; Arroyo J; Barrett AD; Monath TP
    Virology; 1999 May; 257(2):363-72. PubMed ID: 10329547
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Fc portion of antibody to yellow fever virus NS1 is a determinant of protection against YF encephalitis in mice.
    Schlesinger JJ; Foltzer M; Chapman S
    Virology; 1993 Jan; 192(1):132-41. PubMed ID: 8517015
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Monoclonal antibody-based antigen capture immunoassay for detection of circulating non-structural protein NS1: implications for early diagnosis of Japanese encephalitis virus infection.
    Kumar JS; Parida M; Rao PV
    J Med Virol; 2011 Jun; 83(6):1063-70. PubMed ID: 21503922
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Estimation of focus reduction neutralization test for measurement of neutralizing antibody titer against Japanese encephalitis virus.
    Watanabe K; Hirokawa C; Kon M; Tamura T; Nishikawa M
    Jpn J Infect Dis; 2008 Sep; 61(5):424-5. PubMed ID: 18806361
    [No Abstract]   [Full Text] [Related]  

  • 31. High antibody prevalence in an unconventional ecosystem is related to circulation of a low-virulent strain of Japanese encephalitis virus.
    Chiou SS; Tsai KH; Huang CG; Liao YK; Chen WJ
    Vaccine; 2007 Feb; 25(8):1437-43. PubMed ID: 17113688
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Yellow fever outbreak in Ipetu-Ijesa: response after mass vaccination.
    Adu FD; Adeniji JA; Tomori O; Adelasoye A
    Rev Roum Virol; 1993; 44(1-2):3-7. PubMed ID: 8043476
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunization with pseudotype baculovirus expressing envelope protein of Japanese encephalitis virus elicits protective immunity in mice.
    Li Y; Ye J; Cao S; Xiao S; Zhao Q; Liu X; Jin M; Chen H
    J Gene Med; 2009 Feb; 11(2):150-9. PubMed ID: 19040206
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neutralization of Japanese Encephalitis Virus by heme-induced broadly reactive human monoclonal antibody.
    Gupta N; de Wispelaere M; Lecerf M; Kalia M; Scheel T; Vrati S; Berek C; Kaveri SV; Desprès P; Lacroix-Desmazes S; Dimitrov JD
    Sci Rep; 2015 Nov; 5():16248. PubMed ID: 26542535
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Japanese encephalitis protein vaccine candidates expressing neutralizing epitope and M.T hsp70 induce virus-specific memory B cells and long-lasting antibodies in swine.
    Fei-fei G; Jian W; Feng X; Li-ping S; Quan-yun S; Jin-ping Z; Pu-yan C; Pei-hong L
    Vaccine; 2008 Oct; 26(44):5590-4. PubMed ID: 18761388
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preparation and characterization of the monoclonal antibodies against Japanese encephalitis virus.
    Zhang MJ; Wang MX; Jiang SZ; Xiu ZZ; Ma WY
    Acta Virol; 1992 Dec; 36(6):533-40. PubMed ID: 1284867
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Examination of the immunological relationships between flaviviruses using yellow fever virus monoclonal antibodies.
    Gould EA; Buckley A; Cammack N; Barrett AD; Clegg JC; Ishak R; Varma MG
    J Gen Virol; 1985 Jul; 66 ( Pt 7)():1369-82. PubMed ID: 2410549
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antibody responses against wild-type yellow fever virus and the 17D vaccine strain: characterization with human monoclonal antibody fragments and neutralization escape variants.
    Daffis S; Kontermann RE; Korimbocus J; Zeller H; Klenk HD; Ter Meulen J
    Virology; 2005 Jul; 337(2):262-72. PubMed ID: 15919103
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Arbovirus studies in Luanda, Angola. 1. Virological and serological studies during a yellow fever epidemic.
    Pinto MR; Filipe AR
    Bull World Health Organ; 1973; 49(1):31-5. PubMed ID: 4545154
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunological equivalence between mouse brain-derived and Vero cell-derived Japanese encephalitis vaccines.
    Abe M; Shiosaki K; Hammar L; Sonoda K; Xing L; Kuzuhara S; Kino Y; Holland Cheng R
    Virus Res; 2006 Nov; 121(2):152-60. PubMed ID: 16815584
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.